A new drug to potentially treat depression and neurodegenerative diseases, such as dementia or Parkinson’s, is being ...

Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

(“Alpha”) of the improved new drug ZUNVEYL（benzgalantamine delayed-release tablets）(“ZUNVEY” or the “Product”) for the treatment of mild-to-moderate dementia of the Alzheimer’s type. The Group is ...

Cases of dementia in the U.S. are expected to steadily rise in the coming years, hitting 1 million annual cases by 2060.

In a mouse study, researchers found that zolpidem (Ambien), a common sleep aid, could prevent the brain from effectively ...

Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study, out today in ...

(“Alpha”) of the improved new drug ZUNVEYL（benzgalantamine delayed-release tablets）(“ZUNVEY” or the “Product”) for the treatment of mild-to-moderate dementia of the Alzheimer’s ty ...

“We are truly in a new era. We have opened the door to understanding ... based on a blood test as the enrolment criterion for dementia drug trials. That could pave the way for those blood ...

All 16 of Indiana’s designated senior care organizations — known as Area Agencies on Aging — are now required to have a ...

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...

There is no cure for dementia or Alzheimer’s, but certain medications can help temporarily alleviate or slow down some symptoms. There is no cure for dementia or Alzheimer’s disease ...

said other states with similar programs have seen earlier detection and treatment, which can slow the progression of dementia. “This position can both provide consistency — this awareness and ...